TSC Life's Fluido AirGuard System Receives FDA Clearance, Offering Advanced Hypothermia Prevention for Critical Care
TSC Life has secured FDA 510(k) clearance for its Fluido AirGuard System, a moderate to high flow blood and fluid warming solution that addresses critical hypothermia risks in emergency and surgical settings while incorporating advanced safety features to prevent air embolism complications.
TSC Life has received FDA 510(k) clearance for its Fluido AirGuard System, a moderate to high flow blood and IV fluid warming solution designed to prevent hypothermia in critical care settings. The clearance marks a significant advancement in patient safety technology, particularly for emergency care, surgery, ICU, labor and delivery, and severe trauma cases where rapid administration of warm IV fluids or blood products is crucial.
The timing of this innovation addresses a critical medical need, as two-thirds of trauma patients already suffer from mild hypothermia upon arrival in emergency rooms. Medical data shows that just one unit of refrigerated blood or one liter of crystalloid at room temperature can reduce mean body temperature by 0.45° F, highlighting the importance of effective warming systems. The Fluido AirGuard System combines rapid infusion capabilities with enhanced patient safety features, delivering flow rates up to 800 mL/min (48 L/hr) while addressing the dangerous phenomenon of outgassing.
Outgassing, the release of dissolved gasses such as air when fluids are warmed, poses serious risks as bubbles can enter the bloodstream and potentially cause blockages leading to stroke, heart attack, or death. The system features automatic air detection and IV-line clamping technology to prevent air bubbles from entering the bloodstream. Chris Duffie, Commercial VP for the U.S., stated that the system represents a best-in-class combination of clinical utility, patient safety, and cost-efficiency.
The technological advancement comes as TSC Life transitions to building its own direct commercial team in the U.S. market, moving away from reliance on Stryker for distribution. CEO Paraic Curtis emphasized that this strategic shift has accelerated company expansion and strengthened customer relationships while improving U.S. customer care. The company's commitment to the U.S. market is further demonstrated through resources available at https://www.tsc-life.com, where healthcare professionals can learn more about their temperature management solutions.
The Fluido AirGuard System's design includes a removable warming cassette that can move with patients throughout their clinical journey, with pressurization achieved in under 20 seconds. The system's compliance with current safety standards ensures patient safety without compromise, featuring streamlined controls for reliable care. This FDA clearance represents a significant milestone in TSC Life's ongoing mission to develop healthcare solutions that support evidence-based outcomes while allowing providers to focus more on patients and less on device operation.